RACHEL PEARSON: Open Payments
NPI 1659340321 · STRONGSVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,431 in 81 payments from 19 companies in 2025. Trend: 2023 $1,201 · 2024 $1,569 · 2025 $1,431
Food & beverage: $1,431
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $326 |
| ABBVIE INC. | 18 | $237 |
| AstraZeneca Pharmaceuticals LP | 7 | $186 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $138 |
| TOLMAR, INC. | 4 | $100 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Amgen Inc. | 3 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Exact Sciences Corporation | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
Products named: Wegovy, XIFAXAN, Ozempic, QULIPTA, JATENZO, AIRSUPRA, VRAYLAR, BREZTRI.
Industry payments across OH — which companies pay providers there.
